chr11-71473326-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_018161.5(NADSYN1):ā€‹c.508A>Cā€‹(p.Ile170Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00014 ( 0 hom., cov: 34)
Exomes š‘“: 0.0000096 ( 0 hom. )

Consequence

NADSYN1
NM_018161.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.71
Variant links:
Genes affected
NADSYN1 (HGNC:29832): (NAD synthetase 1) Nicotinamide adenine dinucleotide (NAD) is a coenzyme in metabolic redox reactions, a precursor for several cell signaling molecules, and a substrate for protein posttranslational modifications. NAD synthetase (EC 6.3.5.1) catalyzes the final step in the biosynthesis of NAD from nicotinic acid adenine dinucleotide (NaAD).[supplied by OMIM, Apr 2004]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.16494152).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NADSYN1NM_018161.5 linkuse as main transcriptc.508A>C p.Ile170Leu missense_variant 7/21 ENST00000319023.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NADSYN1ENST00000319023.7 linkuse as main transcriptc.508A>C p.Ile170Leu missense_variant 7/211 NM_018161.5 P1Q6IA69-1
NADSYN1ENST00000528509.5 linkuse as main transcriptc.508A>C p.Ile170Leu missense_variant, NMD_transcript_variant 7/101
NADSYN1ENST00000525200.5 linkuse as main transcriptc.409A>C p.Ile137Leu missense_variant, NMD_transcript_variant 6/212
NADSYN1ENST00000529120.5 linkuse as main transcript downstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152208
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000278
AC:
7
AN:
251452
Hom.:
0
AF XY:
0.0000294
AC XY:
4
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.00000958
AC:
14
AN:
1461872
Hom.:
0
Cov.:
31
AF XY:
0.00000963
AC XY:
7
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.000179
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000662
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152208
Hom.:
0
Cov.:
34
AF XY:
0.000134
AC XY:
10
AN XY:
74376
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000478
Bravo
AF:
0.000291
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 23, 2024The c.508A>C (p.I170L) alteration is located in exon 7 (coding exon 7) of the NADSYN1 gene. This alteration results from a A to C substitution at nucleotide position 508, causing the isoleucine (I) at amino acid position 170 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.043
T
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.39
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.16
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.99
L
MutationTaster
Benign
0.67
D
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.23
Sift
Benign
0.50
T
Sift4G
Benign
0.51
T
Polyphen
0.0030
B
Vest4
0.37
MutPred
0.41
Loss of sheet (P = 0.1398);
MVP
0.87
MPC
0.18
ClinPred
0.039
T
GERP RS
1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.22
gMVP
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs769184655; hg19: chr11-71184372; API